|
Items
|
3-yr LRFS
|
3-yr DMFS
|
3-yr OS
|
|---|
| |
%
|
p
|
%
|
p
|
%
|
p
|
|---|
|
Gender
|
|
Male
|
90.1
|
0.356
|
89.3
|
0.387
|
41.8
|
0.980
|
|
Female
|
83.1
|
91.8
|
47.6
|
|
Age (years)
|
|
< 60
|
84.9
|
0.884
|
89.0
|
0.070
|
51.0
|
0.026
|
|
≥ 60
|
87.2
|
100
|
32.4
|
|
rT stage
|
|
rT1–2
|
96.6
|
0.070
|
94.7
|
0.362
|
51.8
|
0.241
|
|
rT3–4
|
77.9
|
88.8
|
42.9
|
|
FD (Gy)
|
|
≤ 2
|
81.6
|
0.298
|
90.3
|
0.820
|
45.5
|
0.645
|
|
> 2
|
94.0
|
93.2
|
47.4
|
|
Use of Chem
|
|
No
|
88.8
|
0.433
|
83.2
|
0.328
|
49.0
|
0.196
|
|
Yes
|
83.8
|
93.9
|
45.1
|
|
TTR (years)
|
|
≤ 2
|
91.7
|
0.248
|
83.9
|
0.035
|
43.6
|
0.977
|
|
> 2
|
82.1
|
94.8
|
47.0
|
|
IMRT dose (Gy)
|
|
< 70
|
85.6
|
0.790
|
93.6
|
0.908
|
42.8
|
0.652
|
|
≥ 70
|
84.7
|
86.1
|
54.0
|
|
Cumulative dose(Gy)
|
|
< 140
|
85.5
|
0.508
|
88.3
|
0.118
|
49.2
|
0.095
|
|
≥ 140
|
88.0
| |
96.2
| |
41.0
| |
|
Brachytherapy
|
|
No
|
79.1
|
0.027
|
90.6
|
0.887
|
44.6
|
0.495
|
|
Yes
|
100
| |
94.4
| |
57.9
| |
- Abbreviations: LRFS, local recurrence–free survival; DMFS, distant metastases–free survival; OS, overall survival; FD, Fractional dose; Chem, chemotherapy; TTR, time to recurrence
